Dumont et al. [93] reviewed data from 12 studies encompassing 2,567 breast cancer patients and uncovered inconsistencies in clinical outcomes; PIK3CA mutations were associated with positive [94,95,96,97], negative [98,99,100], or no significant [101,102,103,104,105] impact survival. This evidence concerns the gene PIK3CA and breast carcinoma.